Johan Willemse

544 total citations
18 papers, 333 citations indexed

About

Johan Willemse is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Johan Willemse has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Johan Willemse's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Johan Willemse is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Johan Willemse collaborates with scholars based in Belgium, Sweden and Austria. Johan Willemse's co-authors include Dirk Hendriks, Evelien Heylen, Michael E. Nesheim, Robert Verkerk, Magnus Polla, Peter Paul De Deyn, Raf Brouns, Rishi Sheorajpanday, Didier De Surgeloose and Judith Leurs and has published in prestigious journals such as Analytical Biochemistry, Clinical Chemistry and Clinica Chimica Acta.

In The Last Decade

Johan Willemse

17 papers receiving 325 citations

Peers

Johan Willemse

HEMAT

CCM

ONCOL

Bart J. van Vlijmen Netherlands

Giuseppe Dell’Elba Italy

Aleksandra Stojanovic‐Terpo United States

W. Witt Germany

Sergio Alonso‐Orgaz Spain

Sudipta Biswas United States

Heather Tibbles United States

Mark Schreuder Netherlands

Margaret F. Veale Australia

Kanagasabai Vadivel United States

Bart J. van Vlijmen Netherlands

Johan Willemse

146 ×1.0

HEMAT

155 ×1.7

80 ×1.1

CCM

23 ×0.4

ONCOL

63 ×1.1

Citations per year, relative to Johan Willemse Johan Willemse (= 1×) peers Bart J. van Vlijmen

Countries citing papers authored by Johan Willemse

Since Specialization

Citations

This map shows the geographic impact of Johan Willemse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Willemse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Willemse more than expected).

Fields of papers citing papers by Johan Willemse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Willemse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Willemse. The network helps show where Johan Willemse may publish in the future.

Co-authorship network of co-authors of Johan Willemse

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Willemse. A scholar is included among the top collaborators of Johan Willemse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Willemse. Johan Willemse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cuykx, Matthias, et al.. (2022). Quality control of total carbon dioxide (CO₂) in serum or plasma using the Abbott Architect is affected by environmental pCO₂ concentrations. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 60(1). 46–53.

Schouwers, Sofie, Inger Brandt, Johan Willemse, et al.. (2011). Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins. Clinica Chimica Acta. 413(1-2). 100–104. 24 indexed citations

Miljić, Predrag, Evelien Heylen, Johan Willemse, et al.. (2010). Thrombin activatable fibrinolysis inhibitor (TAFI): A molecular link between coagulation and fibrinolysis. Srpski arhiv za celokupno lekarstvo. 138(suppl. 1). 74–78. 7 indexed citations

Brouns, Raf, Evelien Heylen, Johan Willemse, et al.. (2009). The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome. Journal of Thrombosis and Haemostasis. 8(1). 75–80. 34 indexed citations

Willemse, Johan, Evelien Heylen, Michael E. Nesheim, & Dirk Hendriks. (2009). Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?. Journal of Thrombosis and Haemostasis. 7(12). 1962–1971. 45 indexed citations

Willemse, Johan, et al.. (2009). Chloral hydrate intoxication in a 3-month-old child: Avoidance of hemodialysis by an immediate determination of trichloroethanol. Clinical Biochemistry. 43(3). 328–330. 7 indexed citations

Heylen, Evelien, Predrag Miljić, Johan Willemse, et al.. (2009). Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia. Thrombosis Research. 124(4). 427–432. 14 indexed citations

Heylen, Evelien, et al.. (2009). Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma. Analytical Biochemistry. 396(1). 152–154. 17 indexed citations

Brouns, Raf, Evelien Heylen, Rishi Sheorajpanday, et al.. (2008). Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients. Clinical Neurology and Neurosurgery. 111(2). 165–170. 25 indexed citations

10.

Matus, Valeria, Johan Willemse, Teresa Quiroga, et al.. (2008). Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages. Clinica Chimica Acta. 401(1-2). 158–161. 7 indexed citations

11.

Willemse, Johan, Alfred Weber, Peter L. Turecek, et al.. (2007). Ethanol dependence of α₁‐antitrypsin C‐terminal Lys truncation mediated by basic carboxypeptidases. Transfusion. 48(2). 314–320. 8 indexed citations

12.

Willemse, Johan, Magnus Polla, Thomas Olsson, & Dirk Hendriks. (2007). Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development. Clinica Chimica Acta. 387(1-2). 158–160. 9 indexed citations

13.

Willemse, Johan, Magnus Polla, & Dirk Hendriks. (2006). The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays. Analytical Biochemistry. 356(1). 157–159. 16 indexed citations

14.

Knecht, Wolfgang, Johan Willemse, Hanna Stenhamre, et al.. (2006). Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down‐regulating fibrinolysis. FEBS Journal. 273(4). 778–792. 28 indexed citations

15.

Willemse, Johan & Dirk Hendriks. (2006). A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation. Clinica Chimica Acta. 371(1-2). 124–129. 3 indexed citations

16.

Deiteren, Kathleen, Georgiana Surpateanu, Kambiz Gilany, et al.. (2006). The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(2). 267–277. 23 indexed citations

17.

Willemse, Johan, Judith Leurs, Robert Verkerk, & Dirk Hendriks. (2005). Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Analytical Biochemistry. 340(1). 106–112. 25 indexed citations

18.

Willemse, Johan & Dirk Hendriks. (2005). Measurement of Procarboxypeptidase U (TAFI) in Human Plasma: A Laboratory Challenge. Clinical Chemistry. 52(1). 30–36. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact